Hansa Biopharma Limited

Active08361712 Private limited company

Incorporated: 15 January 2013 (13 years)
Previously known as: Immago Biosystems Limited (until 8 February 2019)
Oxford Antibodies Limited (until 9 October 2013)
This list may be incomplete. See all names on Companies House
Industry: Research and experimental development on biotechnology (72110)
Directors: Monika Maria Törnsén
Soren Hoffmann
Accounts type: Small
Region: South East
Address: Ashcombe Court
Woolsack Way
Godalming
GU7 1LQ

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 29 January 2027
Last conf. stmt: 15 January 2026

Officers 2 active

Officer details are public data from the Companies House register.

Törnsén, Monika Maria

Director · Appointed 7 August 2026

Swedish

Born July 1978 (48)

Hoffmann, Soren

Director · Appointed 5 July 2024

Danish

Born May 1967 (59)

Officer history (12 former)

7 August 2026

Appointed Törnsén, Monika Maria as Director

7 August 2026

Resigned Sjöström, Christina Sofie as Director

5 July 2024

Appointed Hoffmann, Soren as Director

5 July 2024

Resigned Winter, Ferdinand Gregor as Director

28 February 2024

Appointed Sjöström, Christina Sofie as Director

28 February 2024

Resigned Spota, Donato as Director

31 August 2023

Resigned Tomasson, Ludvik Karl as Director

30 August 2023

Appointed Winter, Ferdinand Gregor as Director

5 February 2020

Appointed Tomasson, Ludvik Karl as Director

5 February 2020

Appointed Spota, Donato as Director

5 February 2020

Resigned Joed, Eva-Maria Viktoria as Director

5 February 2020

Resigned Bjorne, Emanuel Fredrik as Director

10 January 2018

Appointed Joed, Eva-Maria Viktoria as Director

10 January 2018

Appointed Bjorne, Emanuel Fredrik as Director

7 November 2017

Resigned Arvidsson, Nils Göran as Director

19 July 2016

Resigned Crispin, Raymond John, Dr as Director

19 July 2016

Appointed Arvidsson, Nils Göran as Director

19 July 2016

Resigned Scanlan, Charles Denis as Director

19 July 2016

Resigned Crispin, Matthew David Max, Dr as Director

11 March 2014

Appointed Scanlan, Charles Denis as Director

21 August 2013

Resigned Laing, Peter as Director

5 May 2013

Resigned Scanlan, Christopher Neil, Dr as Director

15 February 2013

Appointed Laing, Peter as Director

15 January 2013

Appointed Crispin, Raymond John, Dr as Director

15 January 2013

Appointed Scanlan, Christopher Neil, Dr as Director

15 January 2013

Appointed Crispin, Matthew David Max, Dr as Director

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.

Former controllers (2)

19 July 2016

Ceased Hansa Biopharma AB — Owns 75–100% of shares

19 July 2016

Ceased Matthew David Max Crispin — Owns 25–50% of shares

Financials

Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House

Cash: £49,909
Profit: £1,336

Current Ratio: 2.0x
Return on Equity: 0%

Trend

Shareholder Funds

Balance sheet detail

	2024	2022
Current Assets	£576,514	£267,280
Debtors	£526,605	£245,503
Cash	£49,909	£21,777
Creditors (< 1 year)	£294,231	£161,083
Net Current Assets	£282,283	£106,197
Shareholder Funds	£283,932	£108,254